This is a StreetInsider.com Premium Only Page

Celldex (CLDX) –

Apr 25, 2024 08:01 AM Form DEF 14A Celldex Therapeutics, For: Jun 13

Apr 17, 2024 08:05 AM Celldex (CLDX) Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

Apr 17, 2024 08:01 AM Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria

Mar 8, 2024 07:00 AM Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

Mar 5, 2024 10:30 AM Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference

Mar 5, 2024 10:10 AM Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mar 1, 2024 04:10 PM Form 8-K Celldex Therapeutics, For: Feb 28

Mar 1, 2024 04:09 PM Form 424B5 Celldex Therapeutics,

Feb 29, 2024 09:15 PM Celldex (CLDX) Announces Pricing of $400 mln Public Offering of Common Stock

Feb 29, 2024 09:14 PM Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock

Feb 28, 2024 04:13 PM Form 424B5 Celldex Therapeutics,

Feb 28, 2024 04:01 PM Celldex (CLDX) Announces Proposed $250M Share Offering

Feb 28, 2024 04:01 PM Celldex Therapeutics Announces Proposed Public Offering of Common Stock

Feb 28, 2024 06:04 AM Celldex Therapeutics (CLDX) PT Raised to $35 at Wells Fargo

Feb 26, 2024 12:51 PM Celldex Therapeutics (CLDX) PT Raised to $90 at Guggenheim

Feb 26, 2024 08:19 AM Form 424B5 Celldex Therapeutics,

Feb 26, 2024 07:15 AM Celldex (CLDX) Misses Q4 EPS by 7c

Feb 26, 2024 07:06 AM Form 10-K Celldex Therapeutics, For: Dec 31

Feb 26, 2024 07:02 AM Form 8-K Celldex Therapeutics, For: Feb 26

Feb 26, 2024 07:01 AM Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

Feb 25, 2024 08:40 PM Celldex (CLDX) Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study

Feb 24, 2024 02:05 PM Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria

Feb 20, 2024 02:36 AM Celldex (CLDX) March calls active

Feb 16, 2024 03:35 PM Celldex (CLDX) March call spreader active

Feb 15, 2024 04:06 PM Form 4 Celldex Therapeutics, For: Feb 13 Filed by: Jimenez Freddy A.

Feb 14, 2024 04:18 PM Form SC 13G/A Celldex Therapeutics, Filed by: Point72 Asset Management, L.P.

Feb 14, 2024 12:53 PM Form SC 13G Celldex Therapeutics, Filed by: Kynam Capital Management, LP

Feb 14, 2024 11:49 AM Form SC 13G Celldex Therapeutics, Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Feb 14, 2024 07:38 AM Form SC 13G/A Celldex Therapeutics, Filed by: RTW INVESTMENTS, LP

Feb 13, 2024 05:02 PM Form SC 13G/A Celldex Therapeutics, Filed by: VANGUARD GROUP INC

Feb 13, 2024 09:41 AM Form SC 13G Celldex Therapeutics, Filed by: Polar Capital Holdings Plc

Feb 9, 2024 08:51 AM Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC

Feb 8, 2024 10:12 AM Form SC 13G/A Celldex Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP

Feb 6, 2024 04:01 PM Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Feb 5, 2024 08:01 AM Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024

Jan 26, 2024 05:26 PM Form SC 13G/A Celldex Therapeutics, Filed by: BlackRock Inc.

Jan 4, 2024 04:06 PM Form 4 Celldex Therapeutics, For: Jan 02 Filed by: Martin Samuel Bates

Dec 20, 2023 06:16 AM TD Cowen Starts Celldex Therapeutics (CLDX) at Outperform; 'barzolvolimab has blockbuster potential'

Dec 8, 2023 05:51 AM Celldex (CLDX) call put ratio 1 call to 13 puts with focus on January puts

Dec 7, 2023 02:07 PM Celldex (CLDX) call put ratio 1 call to 21 puts with focus on January puts

Nov 27, 2023 04:15 PM Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx Conference

Nov 20, 2023 04:23 PM Steven Cohen's Point72 Reports 6.6% Passive Stake in Celldex (CLDX)

Nov 20, 2023 04:16 PM Form SC 13G Celldex Therapeutics, Filed by: Point72 Asset Management, L.P.

Nov 10, 2023 05:05 AM Wells Fargo Upgrades Celldex Therapeutics (CLDX) to Equal Weight

Nov 8, 2023 05:04 PM Form 8-K Celldex Therapeutics, For: Nov 07

Nov 8, 2023 05:02 PM Form 424B5 Celldex Therapeutics,

Nov 8, 2023 05:57 AM Celldex (CLDX) Prices 7.43M Share Offering at $27/sh

Nov 7, 2023 11:15 PM Celldex Therapeutics Announces Pricing of Public Offering of Common Stock

Nov 7, 2023 04:02 PM Celldex (CLDX) Announces Proposed Share Offering, Size not Disclosed

Nov 7, 2023 04:02 PM Form 424B5 Celldex Therapeutics,